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Purpose: For rapid spatial mapping of gamma‐aminobutyric acid (GABA) at the 
increased sensitivity and spectral separation for ultra‐high magnetic field strength (7 
tesla [T]) an accelerated edited magnetic resonance spectroscopic imaging technique 
was developed and optimized for the human brain at 7 T.
Methods: A MEGA‐sLASER sequence was used for GABA editing and volume 
selection to maximize editing efficiency and minimize chemical shift displacement 
errors. To accommodate the high bandwidth requirements at 7 T, a single‐shot echo 
planar readout was used for rapid simultaneous encoding of the temporal dimension 
and 1 spatial. B0 and B1 field aspects specific for 7 T were studied together with cor-
rection procedures, and feasibility of the EPSI MEGA‐sLASER technique was tested 
in vivo in 5 healthy subjects.
Results: Localized edited spectra could be measured in all subjects giving spatial 
GABA signal distributions over a central brain region, having 45‐ to 50‐Hz spatial 
intervoxel B0 field variations and up to 30% B1 field deviations. MEGA editing was 
found unaffected by the B0 inhomogeneities for the optimized sequence. The correc-
tion procedures reduced effects of intervoxel B0 inhomogeneities, corrected for spa-
tial editing efficiency variations, and compensated for GABA resonance phase and 
frequency shifts from subtle motion and acquisition instabilities. The optimized os-
cillating echo‐planar gradient scheme permitted full spectral acquisition at 7 T and 
exhibited minimal spectral‐spatial ghosting effects for the selected brain region.
Conclusion: The EPSI MEGA‐sLASER technique was shown to provide time‐effi-
cient mapping of regional variations in cerebral GABA in a central volume of inter-
est with spatial B1 and B0 field variations typical for 7 T.
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1 |  INTRODUCTION
Gamma‐aminobutyric acid (GABA) is the major inhibitory 
neurotransmitter in the central nervous system and is sug-
gested to be involved in psychiatric and neurological con-
ditions, such as schizophrenia,1 depression,2 epilepsy,3 and 
Parkinson’s disease4 as well as healthy brain aging.5 Proton 
magnetic resonance spectroscopy (1H‐MRS) can be used to 
noninvasively assess concentrations of neurometabolites in 
vivo. Spectra from different metabolites can be separated 
because each metabolite has its characteristic resonance 
frequency pattern attributed to the specific chemical en-
vironment. Assessment of less‐abundant neurochemicals, 
such as GABA, is hampered by the overlap of spectra from 
more‐abundant metabolites together with limitations in 
peak linewidths and peak frequency separations.
The J‐coupling between the spins of the three CH2‐
groups of GABA can, however, be utilized to separate 
the GABA signal. With the Mescher‐Garwood (MEGA) 
J‐difference editing technique,6 the J‐coupling between 
the 1.89‐ and the 3.01‐ppm (parts per million) GABA 
resonances is utilized by a selective pulse applied at the 
1.89‐ppm resonance to refocus the J‐coupling evolution 
at the 3.01‐ppm resonance (ON experiment). The J‐evolu-
tion is left undisturbed in a second (OFF) experiment, and 
the 3.01‐ppm GABA resonance is isolated after spectrum 
subtraction.
Further facilitation of the assessment of low‐concentration 
GABA from the 1H‐MRS spectrum can be achieved by an 
increase in magnetic field strength, giving both an increased 
frequency separation between resonances and an increased sen-
sitivity. Although there is still complete overlap of the GABA 
resonance with other resonances at 7 tesla (T), cerebral concen-
trations of GABA have been reported without editing in humans 
at improved precision compared to lower field strengths using 
short echo time single‐voxel localization techniques.7 The accu-
racy of unedited measurement of GABA at short echo time is, 
however, sensitive to experimental conditions.8
The increases in sensitivity and chemical shift disper-
sion are both favorable for GABA editing, but higher field 
strengths also imply hampered signal localization from in-
creased chemical shift displacement (CSD) errors. GABA 
editing using MEGA and semilocalization by adiabatic se-
lective refocusing (MEGA‐sLASER) was demonstrated to 
give efficient spectral editing of the 3.01‐ppm resonance 
with minimal CSD errors at 7 T.9
Studies of regional variations in GABA will benefit 
greatly from spatial mapping of concentrations using mag-
netic resonance spectroscopic imaging (MRSI) techniques. 
MRSI at 7 T requires additional considerations associated 
with the increased spatial variations in the transmitted 
radio frequency field (B1) and the permanent magnetic 
field (B0) that need to be taken into account during data 
acquisition and postprocessing. Also, the increased radio 
frequency (RF) power deposition at high field, in combina-
tion with high‐bandwidth adiabatic pulses, leads to an in-
creased minimum repetition time (TR) as compared to 3 T. 
However, MRSI can be significantly accelerated by simul-
taneous encoding of the temporal and spatial dimensions 
using oscillating readout gradients, as exemplified by, for 
example, spiral gradient sampling10 and the echo planar 
spectroscopic imaging (EPSI) technique.11 Utilizing such 
techniques at 7 T is challenging with respect to gradient 
performance because of the increased bandwidth required 
to sample all metabolite signals critically.
The aim of our study was to develop, optimize, and test 
an accelerated edited MRSI technique for spatial mapping 
of GABA in the human brain at 7 T. The MEGA‐sLASER 
technique was applied for GABA editing and localization, 
in combination with a fast noninterleaved EPSI readout 
to accommodate the high‐bandwidth requirements at 7 T. 
The B0 and B1 field aspects specific for 7 T were studied 
together with correction procedures, and the feasibility of 
the EPSI MEGA‐sLASER technique was demonstrated in 
vivo.
2 |  METHODS
Measurements were performed on a whole‐body 7 T MR 
scanner (Achieva; Philips, Cleveland, OH) interfaced to 
a 2‐channel volume transmit head coil and 32‐channel 
receiver array (Nova Medical, Inc, Burlington, MA). All 
measurements were performed in accord with local ethical 
protocols.
2.1 | Sequence design
A volume‐selective MEGA‐sLASER sequence9 was com-
bined with an echo‐planar gradient waveform during signal 
readout (Figure 1). Frequency offset corrected inversion 
FOCI refocusing pulses12,13 (duration = 5 ms, HSn = 2, 
FOCI factor = 5, B1max = 18 uT) were used in the volume 
selection giving a CSD error of 2.5% between 1.89 and 
3.01 ppm in the refocusing directions. The CSD error along 
the excitation direction from the asymmetric excitation 
pulse was 5%. MEGA editing was performed as described 
elsewhere.9 A crusher gradient configuration minimizing 
stimulated echo contributions was used. To minimize the ef-
fects from spatial B0 variations on the editing performance 
across the volume selection region (volume of interest; 
VOI), Gaussian RF pulses of 5‐ms duration (full width of 
95% maximum of 100 Hz) were used to cover the frequency 
range of the spatial B0 variation over the VOI. The offset fre-
quency was set to 1.9 ppm in the edit ON acquisitions, and to 
7.5 ppm in the edit OFF acquisitions.
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An oscillating echo‐planar (EP) gradient with plateau 
sampling was used for simultaneous readout of the tem-
poral dimension and 1 spatial. The optimized gradient 
waveform had a spectrum bandwidth of 2662 Hz and 62% 
sampling efficiency (slew rate = 133 T/m/s, gradient am-
plitude = 9.4 mT/m, ramp time = 70 us, plateau = 230 us, 
pixel bandwidth = 4.3 kHz, train duration = 192 ms, sample 
points = 512).
Phase encoding was used to cover the second spatial di-
mension. The edit ON/OFF alternation was placed in the 
innermost loop of the scan execution followed by a phase‐en-
coding loop and finally an outer averaging loop. This mini-
mizes subtraction errors between the ON and OFF spectra.
2.2 | Reconstruction, data 
processing, and analysis
The reconstruction and analysis software was developed in‐
house using Matlab (The MathWorks, Inc, Natick, MA). The 
calculation steps were applied in the following order: (1) flip-
ping of odd‐numbered echoes (readout along kx) and correc-
tion for temporal odd‐even echo shifts; (2) spatial domain fast 
Fourier transforms; (3) voxel location‐dependent coil weight 
assessment; (4) coil phase angle assessment and correction; 
(5) voxel location weighted time‐domain signal addition 
over coils; and (6) voxel location phase angle assessment and 
alignment. Steps 1 through 6 were first applied to the water 
reference scan and next to the water‐suppressed scan while 
reapplying the coil weights and phase angles determined from 
the water reference scan. This was, in turn, followed by: (1) 
eddy current compensation (ECC)14,15; (2) regridding of the 
data acquired on the non‐Cartesian kx‐time‐domain trajectory 
to a Cartesian grid; (3) k‐space Hamming filtering; and (4) 
27‐ and 13‐Hz spectral broadening, pre‐ and post choline fre-
quency, and phase alignment (FPA), respectively.
For enhanced separation of edited GABA signals in re-
gions with remaining frequency and phase shifts, spectral 
FPA of the choline peak9,16 was applied as a final processing 
step before subtracting the edit ON and OFF sets to gener-
ate the final GABA and metabolite spectra. The choline peak 
FPA was performed by comparing to the average spectrum 
for the ON and OFF measurement, separately, followed by an 
alignment of the summed ON and OFF spectra using the cho-
line resonance. B1‐mapping17 was included in the scanning 
protocol to enable correction of varying editing efficiency 
(EE). A quantum mechanical simulation (result in Figure 
2) of the effect of the B1 field variation on only the MEGA 
editing pulse and on the EE was performed in VESPA.18,19 
A third‐order polynomial was fitted to the simulated signal 
amplitudes in the normalized B1 field strength range 60% to 
140%, and the resulting EE function was applied to correct 
the edited spectra normalized to the total creatine signal of the 
OFF‐pulse spectra. The Lorentzian line shape was fitted to 
the creatine signals (fit error threshold = 20%). The Gaussian 
line shape (30‐Hz fixed linewidth) was fitted to the GABA+ 
(GABA plus co‐edited macromolecules) signals, using a fit 
error threshold of 30%, to allow fitting of not fully separated 
GABA+ signals. The fit error is the percentage root mean 
square difference between data and line‐shape model.
2.3 | Sequence tests
The performance of the EPSI MEGA‐sLASER sequence 
was tested in vivo in 5 healthy subjects (2 female, 3 male) 
of 25 to 45 years of age. The scanning protocol included 2 
EPSI MEGA‐sLASER sets, a T1‐weighted 3D magnetiza-
tion‐prepared rapid gradient echo, and a 3D gradient echo 
dual TR B1 map.17 The EPSI MEGA‐sLASER imaging plane 
was a transversal midbrain slice above the ventricles (field of 
view = 160 × 160 mm2, slice thickness = 22 mm, VOI = 80 
F I G U R E  1  Sequence diagram for the echo‐planar MEGA‐sLASER sequence with adiabatic refocusing (FOCI) and 5‐ms Gaussian pulses for 
the spectral editing (MEGA) followed by prephase (px) and phase‐encoding (py) gradients before the spatial and temporal encoding echo‐planar 
readout (EPSI)
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× 80 × 22 mm3, matrix size = 16 × 16, B1max = 18 uT, pencil 
beam second‐order shimming, in‐plane voxel size = 10 × 10 
mm2 [effective voxel size = 3.7 mL], TR = 4281 ms, echo 
time = 74 ms).
The protocol further consisted of 1 water‐suppressed scan 
(VAPOR [variable pulse power and optimized relaxation de-
lays],20 window = 200 Hz) of 9 min duration with 4 signal 
averages (number of signals averaged; NSA) and a water ref-
erence scan (duration 2 minutes) with NSA = 1 and with the 
editing pulses turned off.
3 |  RESULTS
Spatially localized ON and OFF spectra were measured in all 
subjects. VOI average and ranges for the spatial distributions 
(Figure 3, row A) of the creatine signal‐to‐noise ratio (SNR) 
of the OFF‐pulse measurement are shown in Supporting 
Information Tables S2, together with the errors in the fit to 
the creatine and corrected GABA+ signals. Corresponding 
spatial distributions of the fit errors are shown in Supporting 
Information Figure 9. VOI ranges for the spatial distributions 
of the normalized B1 field strength deviations (Supporting 
Information Figure 8) are shown in Supporting Information 
Table S1, together with the maximum of the corresponding 
spatial distributions of the EE correction factors (Supporting 
Information Figure 8). The intravoxel B0 field inhomogenei-
ties, assessed from the linewidth of the 3.01‐ppm creatine 
resonance from the OFF measurements, varied as shown in 
Supporting Information Table S1, corresponding to the dis-
tributions in Figure 4 and Supporting Information Figure 
7. Intervoxel B0 field variations, assessed from the creatine 
resonance frequency shifts (Figure 4E), were significantly 
reduced by the ECC and varied in ranges from mini-
mum ± 3 Hz to maximum ± 11 Hz (Supporting Information 
Table S1).
F I G U R E  3  Spatial distributions for the healthy volunteer test scans (no. 1‐no. 5) of the OFF‐pulse measurement creatine (Cr) signal (row A), 
uncorrected GABA+ signal (row B), and Cr‐normalized GABA+ signal after editing efficiency correction and choline peak frequency and phase 
alignment (row C)
F I G U R E  2  Simulated B1 field strength dependence of the signal amplitude of the MEGA edited GABA spin system at 3.01 ppm (sampling 
bandwidth = 2 kHz, 2048 sampling points). The typical normalized B1 field strength range 80% to 125% over the VOI is indicated (blue rectangle)
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The impact on the spatial distribution of the measured 
GABA+ signal from the spectral correction procedures was 
demonstrated for 1 subject (Figure 5 showing the impact 
of creatine normalization, EE correction, and choline peak 
FPA separately). Creatine‐normalized GABA+ levels of 0.22 
were close to uniformly distributed in a central region of the 
VOI, corresponding to white matter, with an elevation to-
ward the left and right VOI edges (Figure 5C). This elevation 
was further enhanced by the EE correction (Figure 5D). The 
choline FPA gave an increased fraction of voxels with fitting 
error below the chosen threshold (Figure 5E and Supporting 
Information Figure S1D).
Uncorrected GABA+ signal distributions are shown 
in Figure 3, row B, for all the 5 scans on healthy subjects. 
The more pronounced choline peak residuals, disabling a fit 
to the uncorrected GABA+ signals in central voxels, was 
present for 1 of the 5 healthy subject scans (Figure 3, row 
B, no. 1). An increase in GABA+ signal toward the left and 
right VOI edges were a general characteristic across subjects 
after Cr normalization (Figure 3, row C). A lower spectral 
quality was observed in some voxels on the VOI edge col-
umns (Supporting Information Figure S1D). A corrected low 
GABA+ signal centrally in the VOI was further apparent for 
2 subjects (Figure 3, row C, no. 2 and no. 4).
4 |  DISCUSSION
An accelerated edited MRSI technique for spatial mapping 
of GABA+ signal in the human brain at 7 T was developed. 
The EPSI MEGA‐sLASER technique was tested in 5 healthy 
subjects and studied with respect to effects from spatial vari-
ations in B0 and B1 fields specific to 7 T.
4.1 | B1 field strength considerations
Simulation of the edited 3.01‐ppm GABA signal shows that 
with increased deviation from the normalized B1 field, the line 
shapes deteriorate along with the signal amplitude (Figure 2). 
The maximum observed deviations from the nominal B1 field 
strength was –31% and –29% (Supporting Information Table 
S1), occurring at the VOI edge (Figure 3, row C, no. 3 and 
no. 5), corresponding to EE correction factors of 1.66 and 
1.58, respectively (Supporting Information Table S1). The 
correction can also be performed for this substantial B1 field 
strength deviation of –30%, but the GABA signal line shapes 
(Figure 2) suggest that corrections may no longer be possible 
for B1 field strength deviations beyond –50%. In order to ap-
proach full brain coverage, other B1 compensation techniques 
will be required.
F I G U R E  4  Spatial distribution for a healthy volunteer test scan (no. 1) of the normalized B1 field strength as measured over the entire image 
plane (A); as resampled to the spatial resolution of the EPSI MEGA‐sLASER sequence, used in calculation of the EE correction (B); and the 
corresponding spatial distribution of the EE correction factor (C). The corresponding spatial distribution of the intravoxel B0 inhomogeneity by 
creatine peak linewidth (D) and the intervoxel B0 inhomogeneity by creatine peak frequency offset (E) are displayed together with the structural 
scan (F)
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4.2 | B0 field strength considerations
For the 5 subjects, the typical intervoxel B0 inhomogenei-
ties were spanning ranges of typically 45 to 50 Hz and 6 to 
11 Hz before and following (Supporting Information Table 
S1, Supporting Information Figure 7) the ECC, respectively, 
with a maximum range of 22 Hz following ECC for subject 
no. 3. The corresponding intravoxel linewidths were in the 
range of 5–32 Hz, with a maximum of 46 Hz for subject no. 
3 (Supporting Information Table S1, Supporting Information 
Figure S2). All B0 inhomogeneities were thereby well within 
the 200‐ and 100‐Hz bandwidths of the water suppression 
(VAPOR) and MEGA editing pulses, respectively. Water 
suppression and MEGA editing were therefore considered 
unaffected by B0 inhomogeneities across the image plane in 
all subjects.
4.3 | GABA+ signal and spatial 
distributions
The voxels on the outermost VOI edge columns with less 
well separated corrected GABA+ signal were typically as-
sociated with a low SNR. The volume selection transition 
region of the FOCI refocusing pulses could, to some extent, 
have affected the signal on the outermost VOI edges. A major 
part of the outermost VOI edge voxels were, however, having 
a well separated GABA+ signal with a quality comparable 
to the inner VOI voxels. The central regions where corrected 
low GABA+ signal were observed for 2 subjects (Figure 3, 
row C, no. 2 and no. 4) could not be identified as to have in-
sufficient spectrum quality from, for example, B0 and B1 field 
effects or from subject motion, suggesting that they are true 
reflections of regional variations in GABA+.
F I G U R E  5  Spatial distribution for a healthy volunteer test scan (no. 1) of the creatine (Cr) signal (A), GABA+ signal (B), Cr normalized 
GABA+ signal (C), EE corrected Cr normalized GABA+ signal (D), and GABA+ signal after choline peak frequency and phase alignment (E). A 
selected central region spectra set (ON‐pulse, OFF‐pulse, Subtracted) of the final spectral‐spatial data is shown for location7,9 (F)
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4.4 | Motion considerations
In the subtracted spectra, subtle motion during scanning is 
most likely the main source of degradation in terms of fre-
quency and phase shifts around the 3.01‐ppm GABA+ signal 
(Figure 5D and Supporting Information Figure S1C). Motion 
artifacts were, to a large extent, corrected by the choline peak 
FPA (Figure 5E and Supporting Information Figure S1D). 
Minimization of larger motion artifacts would likely re-
quire the technique to be combined with prospective motion 
correction.10,21,22
4.5 | Temporal‐spatial gradient readout 
considerations
The oscillating EP gradient was optimized to allow for full 
spectral acquisition in a single shot at a spatial resolution per-
mitted by the sensitivity at 7 T, and to minimize the influence 
of motion on the ON/OFF subtraction pairs. Only the central 
k‐space is critically sampled, and spectral‐spatial ghosting 
is thus expected at positions where the signal from off‐reso-
nance metabolites varies abruptly, that is, at the border be-
tween cerebrospinal fluid (CSF) and gray matter.23 This was 
not observed to be problematic in the volunteer measurements 
for the selected slice, but should be more pronounced near 
more CSF‐containing regions. Negligible deviations were 
observed between the spatiotemporal encoding performed by 
the optimized EP gradient, compared to a corresponding fully 
phase encoded version of the sequence (chemical shift imag-
ing [CSI] MEGA‐sLASER) in separate phantom verification 
measurements (data not shown). No significant scanner drift 
was observed with the optimized EP gradient, although this 
could lead to significant issues if not accounted for.24
Other oscillating gradient readout acceleration strate-
gies, such as spiral readouts with high acceleration factors, 
have been shown feasible at lower field strength.10 The 
higher bandwidth requirements for 7 T may, however, be less 
straightforward to fulfill with spiral gradient trajectories.
4.6 | Total acquisition time and specific 
absorption rate
The EPSI acceleration factor was 16 compared to a fully 
phase encoded acquisition (CSI), giving a total acquisi-
tion time of 9 min with 4 signal averages for acquiring the 
GABA+ signal on a 16 × 16 grid. The specific absorption 
rate (SAR) of the RF pulses was the predominant limiting 
factor determining the minimum TR for the EPSI MEGA‐
sLASER. Shortening of the TR may be possible if less 
SAR‐restrictive localization schemes are realized. Gradient 
offset independent adiabaticity pulses exhibit lower power 
deposition and have successfully been applied at 3 T field 
strength.10 At 7 T, however, these pulses have a less opti-
mal bandwidth and a compromised spectral transition region 
as compared to the FOCI pulse shapes, which could have 
a more pronounced effect on the outermost VOI edges. A 
novel alternative to the VOI selection technique for avoiding 
lipid signals could be to use specialized hardware in terms of 
a separate lipid suppression coil25 in combination with the 
EP readout, following the MEGA pulse set, while excluding 
the SAR intense refocusing part of the sequence. This would 
lead to a further significant reduction of the acquisition time.
5 |  CONCLUSION
A MEGA‐sLASER sequence was combined with an opti-
mized EP readout for accelerated MRSI while utilizing the 
high sensitivity at 7 T (EPSI MEGA‐sLASER). The tech-
nique was fulfilling the high‐bandwidth demands for 7 T 
brain spectroscopy and was demonstrated in 5 healthy sub-
jects to provide time‐efficient mapping of regional variations 
in cerebral GABA+ in a large central VOI with typical spa-
tial B1 and B0 field variations. Effects of motion and acquisi-
tion instability were considered and could, to a large extent, 
be retrospectively corrected. Combining the technique with 
prospective motion correction techniques may lead to further 
improvements in cases of pronounced motion. The technique 
is expected to ultimately benefit studies of neurological and 
psychiatric disorders and healthy brain maturation and aging.
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in the Supporting Information section at the end of the 
article.
FIGURE S1. Mosaic spectra view of the spatial distributions 
of the signals for a healthy volunteer test scan (no1), cor-
responding to Fig. 4, of the ON-pulse measurement (A), the 
OFF-pulse measurement (B), subtracted GABA signal (C), 
and GABA signal after creatine normalization, EE correc-
tion and choline peak frequency and phase alignment (D). 
Example VOI sub-region with correctable (D, orange region) 
remaining choline and creatine residuals in subtracted spectra 
(C, orange region) is indicated
FIGURE S2. Spatial distributions for the healthy volunteer 
measurements of the intra-voxel (creatine peak linewidth) and 
inter-voxel (creatine peak frequency offset) B0 inhomogene-
ity, corresponding to the values in Supporting Information 
Table S1.
FIGURE S3. Spatial distributions for the healthy volunteer 
measurements of the editing efficiency (EE) correction fac-
tor and the normalized B1 field strength, corresponding to the 
values in Supporting Information Table S1.
FIGURE S4. Spatial distributions for the healthy volun-
teer measurements of the errors in the fit to the creatine and 
corrected GABA+ signals, corresponding to the values in 
Supporting Information Table S2.
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